As the U.S. Food and Drug Administration (FDA) proposed, Clene is concluding analyses of its ALS biomarker data with completion planned shortly ...
This study shows that excitatory cholecystokinin (CCK)-expressing neurons in hippocampal area CA3 influence hippocampal-dependent memory using multiple methods to manipulate excitatory CCK-expressing ...
Topline data from registrational trial in stiff person syndrome (SPS) now expected in early 2026; narrowed from previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback